Cargando…

Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody

BACKGROUND: Autoimmune nodopathy with anti-contactin-1 (CNTN1) responds well to rituximab instead of traditional therapies. Although a low-dose rituximab regimen was administered to patients with other autoimmune diseases, such as myasthenia gravis and neuromyelitis optica spectrum disorders, and sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Ying, Zhang, Chao, Yu, Xiaolin, Wang, Wenqing, Zhang, Dong, Bai, Yunfei, Yan, Chuanzhu, Ma, Lin, Li, Anning, Ji, Jian, Cao, Lili, Wang, Qinzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362773/ https://www.ncbi.nlm.nih.gov/pubmed/35958552 http://dx.doi.org/10.3389/fimmu.2022.939062

Ejemplares similares

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy
por: Xu, Qianhui, et al.
Publicado: (2021)

Different binding and pathogenic effect of neurofascin and contactin–1 autoantibodies in autoimmune nodopathies
por: Hecker, Katharina, et al.
Publicado: (2023)

Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
por: Liu, Lili, et al.
Publicado: (2022)

Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies
por: Wang, Wanyu, et al.
Publicado: (2022)

Clinical profile of autoimmune nodopathy with anti‐neurofascin 186 antibody
por: Liu, Bingyou, et al.
Publicado: (2023)

Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
por: Wang, Lijun, et al.
Publicado: (2022)

CIDP/autoimmune nodopathies with nephropathy: a case series study
por: Tang, Yuwei, et al.
Publicado: (2023)

Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies
por: Ren, Yijun, et al.
Publicado: (2023)

Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy
por: Martín-Aguilar, Lorena, et al.
Publicado: (2021)

Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2
por: Bien, Christian G.
Publicado: (2018)

Case report: Anti-CNTN1 antibody-associated nodopathies disease with asymmetric onset
por: Li, Qian, et al.
Publicado: (2023)

Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis
por: Zhen, Chao, et al.
Publicado: (2022)

Effect of monovalency on anti-contactin-1 IgG4
por: Taieb, Guillaume, et al.
Publicado: (2023)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates
por: Dubey, Divyanshu, et al.
Publicado: (2020)

Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis
por: Fehmi, Janev, et al.
Publicado: (2023)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Contactin-1 Is Required for Peripheral Innervation and Immune Homeostasis Within the Intestinal Mucosa
por: Veny, Marisol, et al.
Publicado: (2020)

IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
por: Jentzer, Alexandre, et al.
Publicado: (2022)

Nodopathies in the Early Diagnosis of Axonal Forms of Guillain-Barré Syndrome
por: Urdiales-Sánchez, Sara, et al.
Publicado: (2022)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Clinical spectrum of contactin-associated protein 2 autoimmune encephalitis in children
por: Hu, Wenjing, et al.
Publicado: (2023)

Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
por: Du, Ying, et al.
Publicado: (2022)

Clinical and diagnostic features of anti‐neurofascin‐155 antibody‐positive neuropathy in Han Chinese
por: Wang, Wenqing, et al.
Publicado: (2022)

Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype
por: Cortese, Andrea, et al.
Publicado: (2019)

Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
por: Du, Ying, et al.
Publicado: (2022)

Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions
por: Alaibac, Mauro
Publicado: (2018)

Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy
por: Cao, Shugang, et al.
Publicado: (2023)

Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
por: Wang, Yichen, et al.
Publicado: (2018)

Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature
por: Cheng, Yong-kang, et al.
Publicado: (2023)

Contactin-associated protein-2 and anti-aquaporin-4 antibody positive autoimmune encephalitis secondary to herpes simplex encephalitis: A case report
por: Zhang, Lin-Ming, et al.
Publicado: (2023)

No Evidence for Association of Autism with Rare Heterozygous Point Mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins
por: Murdoch, John D., et al.
Publicado: (2015)

Implication of Contactins in Demyelinating Pathologies
por: Kalafatakis, Ilias, et al.
Publicado: (2021)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
por: Becker, Esther B E, et al.
Publicado: (2012)

Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
por: Faustini, Francesca, et al.
Publicado: (2022)

Rituximab Selectively Suppresses Specific Islet Antibodies
por: Yu, Liping, et al.
Publicado: (2011)

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
por: Nytrova, Petra, et al.
Publicado: (2023)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_96b9te536f5ufoo1qokra3ufep